Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ZIM LABORATORIES LTD.

NSE : ZIMLABBSE : 541400ISIN CODE : INE518E01015Industry : Pharmaceuticals & DrugsHouse : MNC

BSE111.002.4 (+2.21 %)

PREV CLOSE ( ) 108.60

OPEN PRICE ( ) 114.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8721

TODAY'S LOW / HIGH ( )108.70 114.00

52 WK LOW / HIGH ( )59.72 126.95

NSE111.66-1.39 (-1.23 %)

PREV CLOSE( ) 113.05

OPEN PRICE ( ) 113.10

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 74288

TODAY'S LOW / HIGH( ) 110.10 115.00

52 WK LOW / HIGH ( )59.31 127

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984

Management Info

Anwar Siraj Daud - Chairman Anwar Siraj Daud - Managing Director

Registered Office

Address Sadoday Gyan (Ground Floor),Opp. Nadt, Nelson Square, ,
Nagpur,
Maharashtra-440013

Phone 0712-2981960

Email info@zimlab.in

Website www.zimlab.in

Registrars Details

MUFG Intime India Pvt Ltd.

C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai

Listing : BSE, NSE

NEWS

06Jun Zim Laboratories informs about newspap
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..

20May ZIM Laboratories secures marketing aut
ZIM Laboratories has secured Marketing Authorization from Agenzia Italia..

20May Zim Laboratories informs about newspap
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosur..

09Apr ZIM Laboratories invests Rs 89.45 lakh
ZIM Laboratories has invested Rs 89.45 lakh which is AUD 1,35,000 (Austr..

09Apr Zim Laboratories informs about acquisi
With reference to the above and pursuant to Regulation 30 of the Securit..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	32.8099999999998	59.6600000000003
Gross Profit	45.2399999999998	84.0100000000003
Operating Profit	127.35	409.7
Net Sales	1028.54	3704.82

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26544.35 (1.52%)	M.Cap ( in Cr)56225.65
Kwality Pharma (BSE) 2500.00 (7.01%)	M.Cap ( in Cr)2575.48
Unichem Lab (BSE) 453.65 (20.00%)	M.Cap ( in Cr)3085.53
Ajanta Pharma (BSE) 3075.00 (2.09%)	M.Cap ( in Cr)38405.21
Caplin Point Lab (BSE) 2311.25 (2.38%)	M.Cap ( in Cr)17526.02

Shareholding Pattern

	NON-INSTITUTION	69.65%
	PROMOTERS	30.35%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ZIM LABORATORIES LTD.